Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet light-treated whole blood.

Cancelas JA, Rugg N, Fletcher D, Pratt PG, Worsham DN, Dunn SK, Marschner S, Reddy HL, Goodrich RP.

Transfusion. 2011 Jul;51(7):1460-8. doi: 10.1111/j.1537-2995.2010.03027.x. Epub 2011 Jan 28.

PMID:
21275998
[PubMed - indexed for MEDLINE]
2.

Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation.

Reddy HL, Dayan AD, Cavagnaro J, Gad S, Li J, Goodrich RP.

Transfus Med Rev. 2008 Apr;22(2):133-53. doi: 10.1016/j.tmrv.2007.12.003. Review.

PMID:
18353253
[PubMed - indexed for MEDLINE]
3.

White blood cell inactivation after treatment with riboflavin and ultraviolet light.

Marschner S, Fast LD, Baldwin WM 3rd, Slichter SJ, Goodrich RP.

Transfusion. 2010 Nov;50(11):2489-98. doi: 10.1111/j.1537-2995.2010.02714.x. Review.

PMID:
20529002
[PubMed - indexed for MEDLINE]
4.

Pathogen-reduction systems for blood components: the current position and future trends.

Seghatchian J, de Sousa G.

Transfus Apher Sci. 2006 Dec;35(3):189-96. Epub 2006 Nov 15. Review.

PMID:
17110168
[PubMed - indexed for MEDLINE]
5.

Pathogen inactivation of blood components: current status and introduction of an approach using riboflavin as a photosensitizer.

Corbin F 3rd.

Int J Hematol. 2002 Aug;76 Suppl 2:253-7. Review.

PMID:
12430933
[PubMed - indexed for MEDLINE]
6.

The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.

Goodrich RP, Edrich RA, Li J, Seghatchian J.

Transfus Apher Sci. 2006 Aug;35(1):5-17. Epub 2006 Aug 28. Review.

PMID:
16935562
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk